iHuman Inc. IH
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
What this company does
Written from the business description in iHuman Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 April 2026. Every sentence was checked against that document before publication.
Growth
Revenue compounded at +8.7% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each CNY of equity produced 10 cents of profit this year.
The 8-year record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue CNY B | 0.8 | 0.9 | 1.0 | 1.0 | 0.9 | 0.5 | 0.2 | 0.1 |
| Operating income CNY B | 0.1 | 0.1 | 0.2 | 0.1 | −0.1 | −0.0 | −0.3 | −0.0 |
| EBITDA CNY B | 0.1 | 0.1 | 0.2 | 0.1 | −0.0 | −0.0 | −0.3 | −0.0 |
| Income tax CNY B | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
| Net income CNY B | 0.1 | 0.1 | 0.2 | 0.1 | −0.0 | −0.0 | −0.3 | −0.0 |
| Free cash flow CNY B | 0.0 | 0.1 | 0.2 | 0.2 | 0.0 | 0.2 | 0.0 | −0.0 |
| EPS, diluted CNY | 0.36 | 0.36 | 0.66 | 0.41 | −0.14 | −0.21 | −1.52 | −0.11 |
| Dividend / sh CNY | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % | 41 | 36 | — | — | — | — | — | — |
| ROE % | 9.8 | 10.3 | 20.9 | 15.9 | −5.9 | — | — | — |
| Shares out B | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | 0.22 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
This company against its peers
Company facts, as filed
Reconciled in 8 of the 8 fiscal years we could check. 24 checks were skipped: the balance sheet is not tagged before 2019. 12 checks were skipped: cost of revenue is not tagged before 2019. 11 checks were skipped: EPS is not tagged before 2018.